Stem Cell 'Pain Sponge' Fights Osteoarthritis
SereNeuro Therapeutics has unveiled groundbreaking preclinical results for SN101, an innovative cell-based therapy poised to revolutionize chronic osteoarthritis treatment by offering a disease-modifying solution rather than just pain relief. This first-in-class therapy uniquely functions as a "pain sponge" by absorbing inflammatory pain factors while also releasing regenerative molecules to support healthier cartilage and bone remodeling, marking a significant advancement in non-opioid pain management.